DALLA MAN, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.661
EU - Europa 1.721
AS - Asia 1.278
AF - Africa 12
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 8
Totale 17.701
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.641
CN - Cina 873
IT - Italia 417
FI - Finlandia 357
SE - Svezia 277
VN - Vietnam 267
DE - Germania 162
GB - Regno Unito 143
FR - Francia 103
UA - Ucraina 87
IN - India 55
IE - Irlanda 44
NL - Olanda 37
CH - Svizzera 25
KR - Corea 24
ES - Italia 22
CA - Canada 20
TR - Turchia 19
EU - Europa 9
IR - Iran 9
NO - Norvegia 9
NZ - Nuova Zelanda 9
RU - Federazione Russa 8
SA - Arabia Saudita 6
BG - Bulgaria 5
JP - Giappone 5
BE - Belgio 4
DK - Danimarca 4
IL - Israele 4
PK - Pakistan 4
AU - Australia 3
CO - Colombia 3
EC - Ecuador 3
GR - Grecia 3
RO - Romania 3
SG - Singapore 3
TH - Thailandia 3
ZA - Sudafrica 3
AT - Austria 2
DZ - Algeria 2
LT - Lituania 2
MA - Marocco 2
NG - Nigeria 2
RS - Serbia 2
SI - Slovenia 2
UY - Uruguay 2
BD - Bangladesh 1
CZ - Repubblica Ceca 1
GH - Ghana 1
HK - Hong Kong 1
KE - Kenya 1
LB - Libano 1
MY - Malesia 1
PH - Filippine 1
PL - Polonia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
Totale 17.701
Salva come PNG Salva come JPEG
Città #
Fairfield 2.383
Woodbridge 1.667
Houston 1.395
Ann Arbor 1.325
Chandler 1.192
Ashburn 922
Seattle 824
Wilmington 785
Cambridge 771
Jacksonville 441
Princeton 355
Roxbury 281
Dong Ket 263
San Diego 258
Medford 252
Des Moines 201
Nanjing 175
Beijing 171
Guangzhou 137
Helsinki 137
Padova 135
Boardman 128
Shenyang 58
Nanchang 53
Shanghai 52
Hebei 50
Dublin 39
Jiaxing 29
Norwalk 23
Falls Church 22
Pohang 22
Ogden 21
Changsha 20
London 20
Redwood City 20
New York 19
Tianjin 19
Milan 17
Charlottesville 16
Jinan 16
New Delhi 16
Rome 16
Arzignano 15
Valencia 14
Bagnolet 13
Borås 12
Yenibosna 12
Lappeenranta 11
Ningbo 10
Birmingham 9
Kharkiv 9
Oxford 9
Belluno 8
Kilburn 8
Paris 8
Zurich 8
Bern 7
Frankfurt am Main 7
Hamilton 7
Hefei 7
Ithaca 7
Minneapolis 7
New Haven 7
Zhengzhou 7
Bagnaria Arsa 6
Bristol 6
Chiswick 6
Eindhoven 6
Freiburg im Breisgau 6
Islington 6
Kunming 6
Nogara 6
Redlands 6
Treviso 6
Acton 5
Bengaluru 5
Coimbatore 5
Croissy-Beaubourg 5
Mannheim 5
Nanto 5
Oslo 5
Prescot 5
Rockville 5
Sofia 5
Taizhou 5
Three Springs 5
Vif 5
Alexandria 4
Auckland 4
Bologna 4
Capaci 4
Capitol Heights 4
Cedar Lake 4
Chicago 4
Chioggia 4
Da Lat 4
Dalmine 4
Delhi 4
Dronten 4
Fort Huachuca 4
Totale 15.125
Salva come PNG Salva come JPEG
Nome #
Increased Rates of Meal Absorption Do Not Explain Elevated 1-Hour Glucose in Subjects With Normal Glucose Tolerance 148
In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes 131
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 128
A system model of oral glucose absorption: Validation on gold standard data 128
Circadian variability of insulin sensitivity: Physiological input for in silico artificial pancreas 128
Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production. 125
Multiscale Modeling of Insulin Secretion 123
Effect of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on beta-cell function in patients with type 2 diabetes: a model-based approach 123
Modeling Subcutaneous Absorption of Long-Acting Insulin Glargine in Type 1 Diabetes 119
A dynamic risk measure from continuous glucose monitoring data. 118
Meal simulation model of the glucose-insulin system 116
The effect of DPP-4 inhibition with sitagliptin on incretin secretion and on fasting and postprandial glucose turnover in subjects with impaired fasting glucose. 112
Assessment of pulsatile insulin secretion derived from peripheral plasma c-peptide concentrations by nonparametric stochastic deconvolution 112
Assessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests. 110
The University of Virginia/Padova Type 1 Diabetes Simulator Matches the Glucose Traces of a Clinical Trial 109
Long-Term Outcomes of Biliopancreatic Diversion on Glycemic Control, Insulin Sensitivity and Beta Cell Function 109
A model of GLP-1 action on insulin secretion in nondiabetic subjects. 108
Age-Related Changes in Insulin Sensitivity and β-Cell Function Among European-American and African-American Women. 108
Downregulation of the Longevity-Associated Protein SIRT1 in Insulin Resistance and Metabolic Syndrome. Potential Biochemical Mechanisms 108
Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men 107
Assessment of postprandial glucose metabolism: conventional dual- vs. triple-tracer method 106
Intranasal oxytocin fails to acutely improve glucose metabolism in obese men 105
Defects in mitochondrial efficiency and H2O2 emissions in obese women are restored to a lean phenotype with aerobic exercise training 104
Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB) 103
Modular Closed-Loop Control of Diabetes. 103
Pioglitazone decreases fasting and postprandial endogenous glucose production in proportion to decrease in hepatic triglyceride content 101
Diabetes: Models, Signals, and Control. 101
Advancing Our Understanding of the Glucose System via Modeling: A Perspective. 101
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. 101
Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes. 100
MPC based Artificial Pancreas: Strategies for individualization and meal compensation 99
An index of parameter reproducibility accounting for estimation uncertainty: Theory and case study on β-cell responsivity and insulin sensitivity 99
Adiposity and β-cell function: relationships differ with ethnicity and age. 97
Ethnic differences in insulin sensitivity, β-cell function, and hepatic extraction between Japanese and Caucasians: a minimal model analysis. 97
Impaired Insulin Action is Associated with Increased Glucagon Concentrations in Non-Diabetic Humans 97
1054-P: Insulin Sensitivity from Sensor and Pump Data in Youths with Type 1 Diabetes: Hybrid Closed-Loop Validation 97
One-Day Bayesian Cloning of Type 1 Diabetes Subjects: Toward a Single-Day UVA/Padova Type 1 Diabetes Simulator 97
Fully Integrated Artificial Pancreas in Type 1 Diabetes: Modular Closed-Loop Glucose Control Maintains Near Normoglycemia. 96
DHEA in elderly women and DHEA or testosterone in elderly men 95
Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction 95
The oral glucose minimal model: estimation of insulin sensitivity from a meal test 94
Race differences in the association of oxidative stress with insulin sensitivity in African- and European-American women. 94
Co-occurrence of Risk Alleles in or Near Genes Modulating Insulin Secretion Predisposes Obese Youth to Prediabetes 94
Exercise effects on postprandial glucose metabolism in type 1 diabetes: A triple-tracer approach 94
Adjustment of open-loop settings to improve closed-loop results in type 1 diabetes: A multicenter randomized trial 94
Mechanisms of hyperinsulinaemia in apparently healthy non-obese young adults: role of insulin secretion, clearance and action and associations with plasma amino acids 94
Modeling Plasma-to-Interstitium Glucose Kinetics from Multitracer Plasma and Microdialysis Data 93
Effects of the Novel Dual GLP-1R/GCGR Agonist SAR425899 on Postprandial Glucose Metabolism in Overweight/Obese Subjects with Type 2 Diabetes 93
Association between thyrotropin levels and insulin sensitivity in euthyroid obese adolescents 92
Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose: Insight from an in Silico study 92
Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator ∗ 91
Model-Based Quantification of Glucagon-Like Peptide-1-Induced Potentiation of Insulin Secretion in Response to a Mixed Meal Challenge 91
Effects of nonglucose nutrients on insulin secretion and action in people with pre-diabetes. 90
Diabetes-associated common genetic variation and its association with GLP-1 concentrations and response to exogenous GLP-1. 90
A Model for the Estimation of Hepatic Insulin Extraction after a Meal 90
Insulin sensitivity by oral glucose minimal models: validation against clamp 89
In Silico Optimization of Basal Insulin Infusion Rate during Exercise: Implication for Artificial Pancreas. 89
Epicardial and Pericardial Fat in Type 2 Diabetes: Favourable Effects of Biliopancreatic Diversion 89
Hepatic insulin sensitivity in healthy and prediabetic subjects: From a dual- to a single-tracer oral minimal model 89
Effects of Type 2 Diabetes on Insulin Secretion, Insulin Action, Glucose Effectiveness and Postprandial Glucose Metabolism 87
Smart Insulin Therapy Initiation In Insulin-Naive Subjects With Type 2 Diabetes Using Machine Learning 86
Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes? 86
Postprandial Glucose Fluxes and Insulin Sensitivity during Exercise:A Study in Healthy Individuals 86
Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function and Glucose Metabolism in Non-Diabetic Subjects. 86
The effect of a bile Acid sequestrant on glucose metabolism in subjects with type 2 diabetes. 85
Model Predictive Control of Type 1 Diabetes: An In Silico Trial 84
Pulsatile Portal Vein Insulin Delivery Enhances Hepatic Insulin Action and Signaling. 84
Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial 84
Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. 83
Contribution of Endogenous Glucagon-Like Peptide 1 to Glucose Metabolism After Roux-en-Y Gastric Bypass 82
Effects of Hyperglycemia and Hyperinsulinemia on Glucose Turnover during Exercise in Type 1 Diabetes 81
Differential effects of the circadian system and circadian misalignment on insulin sensitivity and insulin secretion in humans 81
Two years of treatment with dehydroepiandrosterone does not improve insulin secretion, insulin action, or postprandial glucose turnover in elderly men or women 80
Measurement of selective effect of insulin on glucose disposal from labeled glucose oral test minimal model 80
Modeling Hepatic Insulin Sensitivity during a Meal: Validation against the Euglycemic-Hyperinsulinemic Clamp. 80
Mechanism of Insulin Resistance in Normal Pregnancy. 80
The UVA/PADOVA Type 1 Diabetes Simulator: New Features. 80
Use of labeled oral minimal model to measure hepatic insulin sensitivity. 80
Incorporation of inhaled insulin into the FDA accepted University of Virginia/Padova Type 1 Diabetes Simulator 79
Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites. 79
Mechanisms underlying the pathogenesis of isolated impaired glucose tolerance in humans 79
Glucose fluxes during OGTT in adolescents assessed by a stable isotope triple tracer method 78
Physical Activity Measured by Physical Activity Monitoring System Correlates with Glucose Trends Reconstructed from Continuous Glucose Monitoring 78
Multicenter outpatient randomized crossover trial of zone-MPC artificial pancreas in type 1 diabetes: effects of initialization strategies 78
Nocturnal Glucose Metabolism in Type 1 Diabetes: A Study Comparing Single Versus Dual Tracer Approaches 78
Diurnal Pattern to Insulin Secretion and Insulin Action in Healthy Individuals 77
Effect of pramlintide on postprandial glucose fluxes in type 1 diabetes 77
Diurnal Pattern of Insulin Action in Type 1 diabetes: Implications for a Closed Loop System. 77
Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance. 76
The Oral Minimal Model Method 76
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes 75
Glucose metabolism during rotational shift-work in healthcare workers 75
Model Predictive Control of glucose concentration in subjects with type 1 diabetes: an in silico trial 75
Impaired insulin signaling in unaffected siblings and patients with first-episode psychosis 75
Prediction of postprandial glycemic exposure: utility of fasting and 2-h glucose measurements alone and in combination with assessment of body composition, fitness, and strength 75
A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations. 74
Model Predictive Control of Type 1 diabetes added to conventional therapy 74
Acute Insulin Resistance and Insulin Secretion in Glucose Tolerant and Intolerant Subjects With and Without Diabetes-associated Variation in TCF7L2 74
Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes. 74
A Model of GLP-1 Action on Insulin Secretion in Nondiabetic Subjects 73
Totale 9.357
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.719
article - articoli 43.176
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 453
selected - selezionate 0
volume - volumi 581
Totale 106.929
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.039 0 0 0 0 0 0 0 0 0 0 544 495
2019/20203.143 563 116 80 252 337 221 282 363 341 296 164 128
2020/20212.837 104 176 74 163 107 335 130 183 421 208 365 571
2021/20223.728 101 539 436 209 129 261 189 375 161 78 315 935
2022/20232.532 610 201 149 203 422 261 6 151 328 37 123 41
2023/20241.360 122 250 162 145 79 82 124 82 71 240 3 0
Totale 17.976